Turkish Pain Behaviour Scale in Adults With Chronic Nonspecific Low Back Pain
Reliability and Validity of the Turkish Pain Behaviour Scale in Adults With Chronic Nonspecific Low Back Pain
Reliability and Validity of the Turkish Pain Behaviour Scale in Adults With Chronic Nonspecific Low Back Pain
Sponsor study identifier
observational
102
1 country
1
Study Start
April 1, 2024
Actual (reported)Primary Completion
June 27, 2025
Actual (reported)Study Completion
June 27, 2025
Actual (reported)The aim of this study was to translate and culturally adapt the Pain Behaviour Scale (PaBS) into Turkish and to evaluate its psychometric properties in adults with chronic nonspecific low back pain. Specifically, the study examined interrater reliability, intrarater reliability, agreement, measurement error, and construct validity of the Turkish version of the PaBS during standardized functional performance tasks.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 27, 2025
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 24, 2023
Actual (reported)November 2, 2023
Actual (reported)April 1, 2024
Actual (reported)June 27, 2025
Actual (reported)June 27, 2025
Actual (reported)Turkish Pain Behaviour Scale (PaBS)
The Turkish Pain Behaviour Scale (PaBS) is a clinician-rated observational measure used to assess the presence and severity of pain behaviors during five standardized physical performance tests. Observed behaviors include sighing, breath-holding, grimacing, guarding, rubbing, and antalgic gait. For each physical performance test, the presence or absence of individual behaviors is recorded and the overall severity of observed pain behavior is rated from 0 to 3. The total PaBS severity score ranges from 0 to 15, with higher scores indicating greater severity of observed pain behaviors. Interrater reliability was evaluated using ratings from two independent raters during the first testing session, and intrarater reliability was evaluated using ratings from the same rater across two testing sessions.
Baseline and approximately 1 week
Oswestry Disability Index (ODI)
Baseline and approximately 1 week
Fear-Avoidance Beliefs Questionnaire (FABQ)
Baseline and approximately 1 week
Short-Form McGill Pain Questionnaire (SF-MPQ)
Baseline and approximately 1 week
MPQ-VAS Pain Intensity
Baseline and approximately 1 week
A total of 102 adults aged 18-55 years with chronic nonspecific low back pain lasting more than 3 months were included in the psychometric validation study. Participants underwent standardized clinical, self-report, and physical performance assessments during two testing sessions separated by approximately one week.
Participants completed self-report measures of pain intensity and characteristics, disability, and fear-avoidance beliefs and performed five standardized physical performance tests: repeated trunk flexion, repeated sit-to-stand, Timed Up and Go, loaded reach, and 50-foot walk. During the first testing session, two independent physiotherapists simultaneously assessed the presence and severity of pain behaviors using the Turkish Pain Behaviour Scale (PaBS). For intrarater reliability, one rater repeated the PaBS assessment during a second testing session approximately one week later. No therapeutic intervention was administered as part of the study assessments.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Adults with chronic nonspecific low back pain were recruited using a non-probabilistic sampling strategy from physical therapy and rehabilitation outpatient clinics of private hospitals and a university-based physiotherapy and rehabilitation education and research laboratory. Eligible participants were aged 18-55 years and had chronic nonspecific low back pain lasting longer than 3 months.
Acıbadem Health Group
Istanbul, None Selected, 34752, Turkey (Türkiye)
Elif E Bayraktar, asst. prof.
Acibadem Healthcare Group
Irmak Çavuşoğlu, asst. prof.
Kırklareli University
Nuray Alaca, assoc. prof.
Acibadem Healthcare Group
Yağmur İldeniz, MSc
Acibadem Healthcare Group
102 participants (actual enrollment reported by the registry).
First Submitted
October 24, 2023
First Posted
November 2, 2023
Study Start
April 1, 2024
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
June 27, 2025
Actual (reported)Study Completion
June 27, 2025
Actual (reported)Last Updated
September 21, 2026
Record last verified: 2026-08
Individual participant data will not be shared due to ethical and data protection considerations.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: